Showing results (31-40 of 95) with videos related to
Sort By:
Pageof 10
Journal of Neuro-Oncology|August 1, 1991
Malignant properties of P635 glioma are independent of glial fibrillary acidic protein expressionA F Chambers, G H Denhardt, S M Wilson, et al.Neurology|September 25, 1999
Neoadjuvant procarbazine, CCNU, and vincristine for anaplastic and aggressive oligodendrogliomaN A Paleologos, D R Macdonald, N A Vick, et al.Hybridoma|January 1, 1983
Monoclonal antibodies to three widely distributed human cell surface antigensM J Mattes, J G Cairncross, L J Old, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Corticosteroid-induced magnetic resonance imaging changes in patients with recurrent malignant gliomaC J Watling, D H Lee, D R Macdonald, et al.Annals of Neurology|October 1, 1989
Selection bias in clinical trials of anaplastic gliomaM J Winger, D R Macdonald, S C Schold, et al.The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|March 9, 1999
Low grade glioma: a measuring radiographic response to radiotherapyG Bauman, P Pahapill, D Macdonald, et al.Investigational New Drugs|January 1, 1996
Phase II trial of docetaxel in patients with recurrent malignant glioma: a study of the National Cancer Institute of Canada Clinical Trials GroupP Forsyth, G Cairncross, D Stewart, et al.Annals of Neurology|October 20, 1998
Malignant glioma: who benefits from adjuvant chemotherapy?L M DeAngelis, P C Burger, S B Green, et al.Annals of Neurology|June 1, 1985
Postoperative contrast enhancement in patients with brain tumorJ G Cairncross, J H Pexman, M P Rathbone, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1990
Response criteria for phase II studies of supratentorial malignant gliomaD R Macdonald, T L Cascino, S C Schold, et al.Pageof 10